Legend Biotech Corporation
Status: Publicly traded
Direct answer
Legend Biotech Corporation is publicly traded on NASDAQ under the ticker LEGN.
Legend Biotech Corporation is a clinical-stage biopharmaceutical firm, operating through its various subsidiaries, dedicated to the discovery and advancement of innovative cell therapies. These treatments primarily target oncological conditions but also address other diseases across the United States, China, and international markets. The company's most advanced investigational therapy is LCAR-B38M, a chimeric...
Can you invest in Legend Biotech Corporation?
Yes. Legend Biotech Corporation trades publicly on NASDAQ as LEGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Legend Biotech Corporation
Detailed equity research is provided by MarketSnap.